Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 104, Issue 3, 2011, Pages 434-443

  Cogno, Ingrid S ^a   Vittar, Natalia B Rumie ^a   Lamberti, Maria Julia ^a   Rivarola, Viviana A ^a  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

Author keywords

Apoptosis; Methyl ester ALA (MAL); Photodynamic therapy (PDT); Small interfering RNA (siRNA); Survivin

Indexed keywords

CASPASE 3; HEAT SHOCK PROTEIN; METHYL 5 AMINOLEVULINIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOTOSENSITIZING AGENT; PROTEIN BAK; PROTEIN BCL 2; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA VECTOR; DOWN REGULATION; DRUG MECHANISM; EXON; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE;

AMINOLEVULINIC ACID; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM METASTASIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 79960180178     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2011.05.001     Document Type: Article

References (47)

1. S.B. Brown, E.A. Brown, and I. Walker The present and future role of photodynamic therapy in cancer treatment Lancet Oncol. 5 2004 497 508 (Pubitemid 39069400)
2. H. Fukuda, A. Casas, and A. Batlle Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy Int. J. Biochem. Cell Biol. 37 2005 272 276 (Pubitemid 39330188)
3. M.G. Alvarez, M.S. Lacelli, V. Rivarola, A. Batlle, and H. Fukuda 5-Aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells J. Environ. Pathol. Toxicol. Oncol. 26 2007 75 82 (Pubitemid 47295559)
4. R. Van Hillegersberg, J.W. Van den Berg, W.J. Kort, O.T. Terpstra, and J.H. Wilson Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats Gastroenterology 103 1992 647 651
5. J.C. Kennedy, R.H. Pottier, and D.C. Pross Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience J. Photochem. Photobiol. B 6 1990 143 148
6. A. Klein, P. Babilas, S. Karrer, M. Landthaler, and R.M. Szeimies Photodynamic therapy in dermatology - an update J. Dtsch. Dermatol. Ges. 6 2008 2008 839 846
7. C.J. Gomer, A. Ferrario, N. Rucker, S. Wong, and A.S. Lee Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization Cancer Res. 51 1991 6574 6579
8. C.J. Gomer, A. Ferrario, and N. Rucker Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation Photochem. Photobiol. 53 1991 275 279
9. M.C. Luna, and C.J. Gomer Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy Cancer Res. 51 1991 4243 4249
10. J.G. Hanlon, K. Adams, A.J. Rainbow, R.S. Gupta, and G. Singh Induction of Hsp60 by photofrin-mediated photodynamic therapy J. Photochem. Photobiol. B 64 2001 55 61 (Pubitemid 33064729)
11. Z. Tong, G. Singh, and A.J. Rainbow Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy Cancer Res. 62 2002 5528 5535
12. Z. Tong, G. Singh, and A.J. Rainbow Activation of the stress-activated JNK and p38 MAP kinases in human cells by photofrin-mediated photodynamic therapy J. Photochem. Photobiol. B 71 2003 77 85 (Pubitemid 37258834)
13. M.G. Alvarez, C. Prucca, M.E. Milanesio, E.N. Durantini, and V. Rivarola Photodynamic activity of a new sensitizer derived from porphyrin-C60 dyad and its biological consequences in a human carcinoma cell line Int. J. Biochem. Cell Biol. 38 2006 2092 2101 (Pubitemid 44397617)
14. N.B. Vittar, J. Awruch, K. Azizuddin, and V. Rivarola Caspase-independent apoptosis, in human MCF-7c3 breast cancer cells, following photodynamic therapy, with a novel water-soluble phthalocyanine Int. J. Biochem. Cell Biol. 42 2010 1123 1131
15. J.C. Lee, and P.R. Young Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms J. Leukocyte Biol. 59 1996 152 157 (Pubitemid 26098701)
16. N.L. Oleinick, and H.H. Evans The photobiology of photodynamic therapy: cellular targets and mechanisms Radiat. Res. 150 1998 S146 S156
17. A.P. Castano, P. Mroz, and M.R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 6 2006 535 545 (Pubitemid 43980542)
18. A.K. Verrico, A.K. Haylett, and J.V. Moore In vivo expression of the collagen-related heat shock protein HSP47, following hyperthermia or photodynamic therapy Lasers Med. Sci. 16 2001 192 198 (Pubitemid 32606449)
19. M. Korbelik, J. Sun, and I. Cecic Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response Cancer Res. 65 3 2005 1018 1026 (Pubitemid 40216464)
20. X. Thomas, L. Campos, C. Mounier, J. Cornillon, P. Flandrin, Q.H. Le, S. Piselli, and D. Guyotat Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia Leukemia Res. 29 2005 1049 1058 (Pubitemid 40982599)
21. A. Duval, D. Olaru, L. Campos, P. Flandrin, N. Nadal, and D. Guyotat Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes Haematologica 91 2006 713 714 (Pubitemid 43799480)
22. A. Ferrario, N. Rucker, S. Wong, M. Luna, and C.J. Gomer Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response Cancer Res. 67 2007 4989 4995 (Pubitemid 46910208)
23. N.R. Wall, D.S. O'Connor, J. Plescia, Y. Pommier, and D.C. Altieri Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res. 63 2003 230 235 (Pubitemid 36070444)
24. X. Jiang, C. Wilford, S. Duensing, K. Munger, G. Jones, and D. Jones Participation of survivin in mitotic and apoptotic activities of normal and tumor-derived cells J. Cell. Biochem. 83 2001 342 354 (Pubitemid 32896603)
25. D.C. Altieri Cytokinesis, apoptosis and survivin: three for tango? Cell Death Differ. 8 2001 4 5 (Pubitemid 32162215)
26. S.M. Lens, G. Vader, and R.H. Medema The case for survivin as mitotic regulator Curr. Opin. Cell Biol. 18 2006 616 622 (Pubitemid 44711886)
27. P.M. Canovas, and T.M. Guadagno Functional analysis of Survivin in spindle assembly in Xenopus egg extracts J. Cell. Biochem. 100 2007 217 229 (Pubitemid 44958192)
28. D. Grossman, and D.C. Altieri Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets Cancer Metast. Rev. 20 2001 3 11 (Pubitemid 34074673)
29. T. Nomura, M. Yamasaki, Y. Nomura, and H. Mimata Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells Oncol. Rep. 14 2005 993 997
30. F. Li, J. Yang, N. Ramnath, M.M. Javle, and D. Tan Nuclear or cytoplasmic expression of survivin: what is the significance? Int. J Cancer 114 2005 509 512 (Pubitemid 40349608)
31. A.R. Hinnis, J.C. Luckett, and R.A. Walker Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients Brit. J. Cancer 96 2007 639 645
32. J.M. Gaullier, K. Berg, Q. Peng, H. Anholt, P.K. Selbo, L.W. Ma, and J. Moan Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture Cancer Res. 57 1997 1481 1486 (Pubitemid 27175564)
33. L. Wyld, M.W.R. Reed, and N.J. Brown Differential cell death response to photodynamic therapy is dependent on dose and cell type Brit. J. Cancer 84 2001 1384 1386 (Pubitemid 32522108)
34. D.O. Croci, I.S. Cogno, N.B. Vittar, E. Salvatierra, F. Trajtenberg, O.L. Podhajcer, E. Osinaga, G.A. Rabinovich, and V.A. Rivarola Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway J. Cell. Biochem. 105 2008 381 390
35. W. Shi, C. Bastianutto, A. Li, B. Perez-Ordonez, R. Ng, K.Y. Chow, W. Zhang, I. Jurisica, K.W. Lo, A. Bayley, J. Kim, B. O'Sullivan, L. Siu, E. Chen, and F.F. Liu Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling Int. J. Cancer 119 2006 2467 2475 (Pubitemid 44546973)
36. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 58 2006 621 681
37. P. Fortugno, E. Beltrami, J. Plescia, J. Fontana, D. Pradhan, P.C. Marchisio, W.C. Sessa, and D.C. Altieri Regulation of survivin function by Hsp90 Proc. Natl. Acad. Sci. USA 100 2003 13791 13796 (Pubitemid 37499145)
38. X.M. Yin, Z.N. Oltvai, and S.J. Korsmeyer BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax Nature 369 1994 321 323 (Pubitemid 24159542)
39. C.J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong Photodynamic therapy: combined modality approaches targeting the tumor microenvironment Lasers Surg. Med. 38 2006 516 521
40. A. Ferrario, C.F. Chantrain, K. von Tiehl, S. Buckley, N. Rucker, D.R. Shalinsky, H. Shimada, Y.A. DeClerck, and C.J. Gomer The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model Cancer Res. 64 2004 2328 2332 (Pubitemid 38523882)
41. G.F. He, M.L. Bian, Y.W. Zhao, Q. Xiang, H.Y. Li, and C. Xiao A study on the mechanism of 5-aminolevulinic acid photodynamic therapy in vitro and in vivo in cervical cancer Oncol. Rep. 21 2009 861 868
42. A. Ferrario, and C.J. Gomer Targeting the 90 kDa heat shock protein improves photodynamic therapy Cancer Lett. 289 2010 188 194
43. I. Tamm, Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res. 58 1998 5315 5320 (Pubitemid 28551107)
44. H.W. Wang, T.V. Sharp, A. Koumi, G. Koentges, and C. Boshoff Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin EMBO J. 21 2002 2602 2615 (Pubitemid 34619376)
45. C. Vogel, C. Hager, and H. Bastians Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation Cancer Res. 67 2007 339 345 (Pubitemid 46142793)
46. R.I. You, M.C. Chen, H.W. Wang, Y.C. Chou, C.H. Lin, and S.L. Hsieh Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3 Cancer Res. 66 2006 3051 3061
47. D. Miles, G. von Minckwitz, and A.D. Seidman Combination versus sequential single-agent therapy in metastatic breast cancer Oncologist 7 Suppl. 6 2002 13 19 (Pubitemid 36008992)